1. Home
  2. Stocks
  3. Rossari Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • Similar Stocks
  • FAQs

    • Rossari Biotech Share Price

    Small Cap
    ₹863.1
    + 0.65 (0.08%)
    15 October, 2024 20:54 BSE: 543213 NSE: ROSSARI ISIN: INE02A801020

    Start SIP in Rossari Biotech

    Start SIP

    Rossari Biotech Performance

    Day Range

    • Low 856
    • High 875
    ₹ 863

    52 Week Range

    • Low 657
    • High 973
    ₹ 863
    • Open Price867
    • Previous Close862
    • Volume30179

    Rossari Biotech Chart

    • Over 1 Month -3.71%
    • Over 3 Month + 7.56%
    • Over 6 Month + 19.08%
    • Over 1 Year + 5.69%

    Rossari Biotech Key Statistics

    P/E Ratio 35
    PEG Ratio 1.3
    Market Cap Cr 4,772
    Price to Book Ratio 4.6
    EPS 17.6
    Dividend 0.1
    Relative Strength Index 41.77
    Money Flow Index 13.05
    MACD Signal -7.01
    Average True Range 25.24

    Rossari Biotech Investment Rating

    • Master Rating:

    • Rossari Biotech has an operating revenue of Rs. 1,909.60 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 10% is healthy, ROE of 12% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 7% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 73 which is a FAIR score but needs to improve its earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 38 indicates it belongs to a strong industry group of Diversified Operations and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Rossari Biotech Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 301314299332258264
    Operating Expenses Qtr Cr 261272258290223228
    Operating Profit Qtr Cr 404241423536
    Depreciation Qtr Cr 676667
    Interest Qtr Cr 223321
    Tax Qtr Cr 899987
    Net Profit Qtr Cr 242626262223
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,210979
    Operating Expenses Annual Cr 1,042853
    Operating Profit Annual in Cr 161123
    Depreciation Cr 2426
    Interest Annual Cr 105
    Tax Annual Cr 3424
    Net Profit Annual Cr 10071
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 74114
    Cash from Investing Activity Annual Cr -70-161
    Cash from Financing Annual Activity Cr -2261
    Net Cash Flow Annual Cr -1814
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 960859
    Fixed Assets Annual Cr 192169
    Total Non Current Assets Annual Cr 713655
    Total Current Assets Annual Cr 568471
    Total Assets Annual Cr 1,2811,126
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 174156
    ROE Annual % 108
    ROCE Annual % 1411
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1413
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 490473464483411406
    Operating Expenses Qtr Cr 425409400420353352
    Operating Profit Qtr Cr 656464645855
    Depreciation Qtr Cr 151615151416
    Interest Qtr Cr 434564
    Tax Qtr Cr 12111312108
    Net Profit Qtr Cr 353434332929
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,8381,661
    Operating Expenses Annual Cr 1,5811,433
    Operating Profit Annual in Cr 250223
    Depreciation Cr 6063
    Interest Annual Cr 1922
    Tax Annual Cr 4737
    Net Profit Annual Cr 131107
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 43152
    Cash from Investing Activity Annual Cr -103-181
    Cash from Financing Annual Activity Cr 1661
    Net Cash Flow Annual Cr -4432
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,048915
    Fixed Assets Annual Cr 506481
    Total Non Current Assets Annual Cr 727646
    Total Current Assets Annual Cr 845721
    Total Assets Annual Cr 1,5721,368
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 190166
    ROE Annual % 1212
    ROCE Annual % 1716
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1414
    Invest in Rossari Biotech

    Rossari Biotech Technicals

    EMA & SMA

    Current Price
    ₹863.1
    + 0.65 (0.08%)
    pointer
    • Bullish Moving Average
    • ___
    • 7
    • Bearish Moving Average
    • ___
    • 9
    • 20 Day
    • ₹880.85
    • 50 Day
    • ₹879.42
    • 100 Day
    • ₹851.26
    • 200 Day
    • ₹819.96
    • 20 Day
    • ₹894.22
    • 50 Day
    • ₹899.16
    • 100 Day
    • ₹839.84
    • 200 Day
    • ₹792.57

    Rossari Biotech Resistance and Support

    PIVOT
    ₹864.6
    Resistance
    First Resistance 873.20
    Second Resistance 883.30
    Third Resistance 891.90
    RSI 41.77
    MFI 13.05
    MACD Single Line -7.01
    MACD -12.28
    Support
    First Support 854.50
    Second Support 845.90
    Third Supoort 835.80

    Rossari Biotech Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 64,165 3,764,561 58.67
    Week 52,164 2,606,113 49.96
    1 Month 137,944 6,190,942 44.88
    6 Month 196,076 8,135,183 41.49

    Rossari Biotech Result Highlights

    Rossari Biotech Synopsis

    NSE-Diversified Operations

    Rossari Biotech is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 1202.91 Cr. and Equity Capital is Rs. 11.05 Cr. for the Year ended 31/03/2024. Rossari Biotech Ltd. is a Public Limited Listed company incorporated on 10/08/2009 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH2009PLC194818 and registration number is 194818.
    Market Cap 4,768
    Sales 1,245
    Shares in Float 1.77
    No of funds 68
    Yield 0.06
    Book Value 4.96
    U/D Vol ratio 1.1
    LTDebt / Equity 3
    Alpha -0.04
    Beta 0.65

    Rossari Biotech Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23
    Promoters 68.32%68.32%68.33%
    Mutual Funds 12.96%13.27%13.93%
    Insurance Companies 3.74%4.39%4.09%
    Foreign Portfolio Investors 3.83%4.02%4.14%
    Financial Institutions/ Banks 0.06%
    Individual Investors 9.96%9.14%8.76%
    Others 1.13%0.86%0.75%

    Rossari Biotech Management

    Name Designation
    Mr. Edward Menezes Executive Chairman
    Mr. Sunil Chari Managing Director
    Mr. Aseem Dhru Independent Director
    Maj.Gen.(Retd.) Sharabh Pachory Independent Director
    Ms. Aparna Sharma Independent Director
    Ms. Esha Achan Independent Director

    Rossari Biotech Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Rossari Biotech Corporate Action

    Date Purpose Remarks
    2024-10-19 Quarterly Results
    2024-07-20 Quarterly Results
    2024-04-29 Audited Results & Final Dividend
    2024-01-20 Quarterly Results
    2023-10-21 Quarterly Results

    Rossari Biotech FAQs

    What is Share Price of Rossari Biotech ?

    Rossari Biotech share price is ₹863 As on 15 October, 2024 | 20:40

    What is the Market Cap of Rossari Biotech ?

    The Market Cap of Rossari Biotech is ₹4772 Cr As on 15 October, 2024 | 20:40

    What is the P/E ratio of Rossari Biotech ?

    The P/E ratio of Rossari Biotech is 35 As on 15 October, 2024 | 20:40

    What is the PB ratio of Rossari Biotech ?

    The PB ratio of Rossari Biotech is 4.6 As on 15 October, 2024 | 20:40

    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

    Q2FY23

    5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.